{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:40:08Z","timestamp":1758721208013,"version":"3.44.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100022804","name":"Eva Mayr-Stihl Stiftung","doi-asserted-by":"publisher","award":["FP00017"],"award-info":[{"award-number":["FP00017"]}],"id":[{"id":"10.13039\/501100022804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"DOI":"10.1186\/s12904-025-01871-7","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T09:13:07Z","timestamp":1758618787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Life after hepatorenal syndrome: unraveling quality of life, psychological distress, and treatment preferences"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8849-5101","authenticated-orcid":false,"given":"J.","family":"M\u00fcller-K\u00fchnle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7300-8132","authenticated-orcid":false,"given":"M.","family":"Schanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0584-4870","authenticated-orcid":false,"given":"J.","family":"Latus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1639-8762","authenticated-orcid":false,"given":"D.","family":"Marschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6770-3056","authenticated-orcid":false,"given":"S.","family":"Schricker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"issue":"6","key":"1871_CR1","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1053\/j.ajkd.2011.12.032","volume":"59","author":"C Fagundes","year":"2012","unstructured":"Fagundes C, Gin\u00e8s P. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis. Am J Kidney Dis. 2012;59(6):874\u201385.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1871_CR2","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3350\/cmh.2023.0024","volume":"29","author":"CY Jung","year":"2023","unstructured":"Jung CY, Chang JW. Hepatorenal syndrome: current concepts and future perspectives. Clin Mol Hepatol. 2023;29(4):891\u2013908.","journal-title":"Clin Mol Hepatol"},{"issue":"45","key":"1871_CR3","doi-asserted-by":"publisher","first-page":"7831","DOI":"10.3748\/wjg.v27.i45.7831","volume":"27","author":"W Kaewput","year":"2021","unstructured":"Kaewput W, et al. In-hospital mortality of hepatorenal syndrome in the united states: nationwide inpatient sample. World J Gastroenterol. 2021;27(45):7831\u201343.","journal-title":"World J Gastroenterol"},{"key":"1871_CR4","doi-asserted-by":"crossref","unstructured":"Thursz M, et al. EASL clinical practice guidelines: management of alcohol-related liver disease. J Hepatol. 2018;69(1):154\u201381.","DOI":"10.1016\/j.jhep.2018.03.018"},{"issue":"13","key":"1871_CR5","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1056\/NEJMra0809139","volume":"361","author":"P Gin\u00e8s","year":"2009","unstructured":"Gin\u00e8s P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361(13):1279\u201390.","journal-title":"N Engl J Med"},{"issue":"30","key":"1871_CR6","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.3748\/wjg.v13.i30.4046","volume":"13","author":"S Turban","year":"2007","unstructured":"Turban S, Thuluvath PJ, Atta MG. Hepatorenal syndrome. World J Gastroenterol. 2007;13(30):4046\u201355.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"1871_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4254\/wjh.v5.i12.685","volume":"5","author":"A Licata","year":"2013","unstructured":"Licata A, et al. Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study. World J Hepatol. 2013;5(12):685\u201391.","journal-title":"World J Hepatol"},{"issue":"1","key":"1871_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1665-2681(19)32154-4","volume":"2","author":"A C\u00e1rdenas","year":"2003","unstructured":"C\u00e1rdenas A, Arroyo V. Hepatorenal syndrome. Ann Hepatol. 2003;2(1):23\u20139.","journal-title":"Ann Hepatol"},{"issue":"4","key":"1871_CR9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","volume":"64","author":"P Angeli","year":"2015","unstructured":"Angeli P, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the international club of Ascites. Gut. 2015;64(4):531\u20137.","journal-title":"Gut"},{"issue":"2","key":"1871_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S2468-1253(16)30157-1","volume":"2","author":"A Facciorusso","year":"2017","unstructured":"Facciorusso A, et al. Comparative efficacy of Pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(2):94\u2013102.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"1871_CR11","doi-asserted-by":"publisher","first-page":"e1307","DOI":"10.1097\/01.HC9.0000897228.91307.0c","volume":"7","author":"MP Curry","year":"2023","unstructured":"Curry MP, et al. Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies. Hepatol Commun. 2023;7(1):e1307.","journal-title":"Hepatol Commun"},{"issue":"5","key":"1871_CR12","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s10620-019-05858-2","volume":"65","author":"MJ Thomson","year":"2020","unstructured":"Thomson MJ, et al. Limited progress in hepatorenal syndrome (HRS) reversal and survival 2002\u20132018: A systematic review and Meta-Analysis. Dig Dis Sci. 2020;65(5):1539\u201348.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"1871_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/00007890-199502150-00010","volume":"59","author":"TA Gonwa","year":"1995","unstructured":"Gonwa TA, et al. Impact of pretransplant renal function on survival after liver transplantation. Transplantation. 1995;59(3):361\u20135.","journal-title":"Transplantation"},{"issue":"11","key":"1871_CR14","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/lt.22395","volume":"17","author":"TD Boyer","year":"2011","unstructured":"Boyer TD, et al. Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1. Liver Transpl. 2011;17(11):1328\u201332.","journal-title":"Liver Transpl"},{"issue":"1","key":"1871_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5935\/0103-507X.20170013","volume":"29","author":"SH Loss","year":"2017","unstructured":"Loss SH, et al. Chronic critical illness: are we saving patients or creating victims? Rev Bras Ter Intensiva. 2017;29(1):87\u201395.","journal-title":"Rev Bras Ter Intensiva"},{"issue":"568","key":"1871_CR16","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.3399\/bjgp09X453990","volume":"59","author":"IT Heyworth","year":"2009","unstructured":"Heyworth IT, et al. How do common chronic conditions affect health-related quality of life? Br J Gen Pract. 2009;59(568):e353\u20138.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"1871_CR17","first-page":"80","volume":"21","author":"RL Hickman Jr","year":"2010","unstructured":"Hickman RL Jr., Douglas SL. Impact of chronic critical illness on the psychological outcomes of family members. AACN Adv Crit Care. 2010;21(1):80\u201391.","journal-title":"AACN Adv Crit Care"},{"key":"1871_CR18","doi-asserted-by":"publisher","first-page":"1111677","DOI":"10.3389\/frhs.2023.1111677","volume":"3","author":"O Abdelhadi","year":"2023","unstructured":"Abdelhadi O. The impact of psychological distress on quality of care and access to mental health services in cancer survivors. Front Health Serv. 2023;3:1111677.","journal-title":"Front Health Serv"},{"issue":"1","key":"1871_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1164\/rccm.201704-0720OC","volume":"197","author":"CE Cox","year":"2018","unstructured":"Cox CE, et al. Effects of a Telephone- and Web-based coping skills training program compared with an education program for survivors of critical illness and their family members. A randomized clinical trial. Am J Respir Crit Care Med. 2018;197(1):66\u201378.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1871_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/SGA.0000000000000108","volume":"38","author":"L Hansen","year":"2015","unstructured":"Hansen L, et al. Symptom distress in patients with end-stage liver disease toward the end of life. Gastroenterol Nurs. 2015;38(3):201\u201310.","journal-title":"Gastroenterol Nurs"},{"issue":"1","key":"1871_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/CLD.0000000000000044","volume":"22","author":"K Miller","year":"2023","unstructured":"Miller K, Barman P, Kappus M. Palliative care and end of life care in decompensated cirrhosis. Clin Liver Dis (Hoboken). 2023;22(1):10\u20133.","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"2","key":"1871_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1440-1819.2006.01483.x","volume":"60","author":"JH Sorrell","year":"2006","unstructured":"Sorrell JH, et al. Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation. Psychiatry Clin Neurosci. 2006;60(2):174\u201381.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"1871_CR23","doi-asserted-by":"publisher","first-page":"2363654","DOI":"10.1080\/20008066.2024.2363654","volume":"15","author":"G Navarra-Ventura","year":"2024","unstructured":"Navarra-Ventura G, et al. Occurrence, co-occurrence and persistence of symptoms of depression and post-traumatic stress disorder in survivors of COVID-19 critical illness. Eur J Psychotraumatol. 2024;15(1):2363654.","journal-title":"Eur J Psychotraumatol"},{"issue":"1","key":"1871_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12888-020-02632-x","volume":"20","author":"S Tripathy","year":"2020","unstructured":"Tripathy S, et al. Post traumatic stress symptoms, anxiety, and depression in patients after intensive care unit discharge - a longitudinal cohort study from a LMIC tertiary care centre. BMC Psychiatry. 2020;20(1):220.","journal-title":"BMC Psychiatry"},{"key":"1871_CR25","doi-asserted-by":"publisher","first-page":"205031211667172","DOI":"10.1177\/2050312116671725","volume":"4","author":"L Lins","year":"2016","unstructured":"Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: scoping review. SAGE Open Med. 2016;4:2050312116671725.","journal-title":"SAGE Open Med"},{"issue":"31","key":"1871_CR26","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.3748\/wjg.v28.i31.4442","volume":"28","author":"T Ishinuki","year":"2022","unstructured":"Ishinuki T, et al. Current standard values of health utility scores for evaluating cost-effectiveness in liver disease: A meta-analysis. World J Gastroenterol. 2022;28(31):4442\u201355.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1871_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/gut.45.2.295","volume":"45","author":"ZM Younossi","year":"1999","unstructured":"Younossi ZM, et al. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45(2):295\u2013300.","journal-title":"Gut"},{"key":"1871_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1477-7525-6-11","volume":"6","author":"CC Wee","year":"2008","unstructured":"Wee CC, Davis RB, Hamel MB. Comparing the SF-12 and SF-36 health status questionnaires in patients with and without obesity. Health Qual Life Outcomes. 2008;6:11.","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"1871_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1055\/s-0035-1564794","volume":"32","author":"B Erly","year":"2015","unstructured":"Erly B, et al. Hepatorenal syndrome: A review of pathophysiology and current treatment options. Semin Intervent Radiol. 2015;32(4):445\u201354.","journal-title":"Semin Intervent Radiol"},{"key":"1871_CR30","doi-asserted-by":"crossref","unstructured":"Badura K, et al. Hepatorenal syndrome - novel insights into diagnostics and treatment. Int J Mol Sci. 2023;24(24):17469.","DOI":"10.3390\/ijms242417469"},{"issue":"1","key":"1871_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s43441-020-00195-3","volume":"55","author":"JJ Lundy","year":"2021","unstructured":"Lundy JJ, et al. Collection of Post-treatment PRO data in oncology clinical trials. Ther Innov Regul Sci. 2021;55(1):111\u20137.","journal-title":"Ther Innov Regul Sci"},{"key":"1871_CR32","first-page":"61","volume":"6","author":"T Weldring","year":"2013","unstructured":"Weldring T, Smith SM. Patient-Reported outcomes (PROs) and Patient-Reported outcome measures (PROMs). Health Serv Insights. 2013;6:61\u20138.","journal-title":"Health Serv Insights"},{"issue":"2","key":"1871_CR33","first-page":"129","volume":"37","author":"SD Faulkner","year":"2023","unstructured":"Faulkner SD, et al. Using patient perspectives to inform better clinical trial design and conduct: current trends and future directions. Pharmaceut Med. 2023;37(2):129\u201338.","journal-title":"Pharmaceut Med"},{"issue":"1","key":"1871_CR34","doi-asserted-by":"publisher","first-page":"6026","DOI":"10.1038\/s41467-022-33826-4","volume":"13","author":"OL Aiyegbusi","year":"2022","unstructured":"Aiyegbusi OL, et al. Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection. Nat Commun. 2022;13(1):6026.","journal-title":"Nat Commun"},{"issue":"6","key":"1871_CR35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4254\/wjh.v9.i6.293","volume":"9","author":"JG Acevedo","year":"2017","unstructured":"Acevedo JG, Cramp ME. Hepatorenal syndrome: update on diagnosis and therapy. World J Hepatol. 2017;9(6):293\u20139.","journal-title":"World J Hepatol"},{"issue":"3","key":"1871_CR36","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1475-6773.2005.00391.x","volume":"40","author":"H Liu","year":"2005","unstructured":"Liu H, et al. Imputation of SF-12 health scores for respondents with partially missing data. Health Serv Res. 2005;40(3):905\u201321.","journal-title":"Health Serv Res"},{"issue":"3","key":"1871_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.24095\/hpcdp.29.3.03","volume":"29","author":"WM Hopman","year":"2009","unstructured":"Hopman WM, et al. Associations between chronic disease, age and physical and mental health status. Chronic Dis Can. 2009;29(3):108\u201316.","journal-title":"Chronic Dis Can"},{"issue":"4","key":"1871_CR38","first-page":"405","volume":"17","author":"N Svirtlih","year":"2008","unstructured":"Svirtlih N, et al. Reduced quality of life in patients with chronic viral liver disease as assessed by SF12 questionnaire. J Gastrointestin Liver Dis. 2008;17(4):405\u20139.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"1","key":"1871_CR39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12876-021-01890-7","volume":"21","author":"D Gazineo","year":"2021","unstructured":"Gazineo D, et al. Health-related quality of life in outpatients with chronic liver disease: a cross-sectional study. BMC Gastroenterol. 2021;21(1):318.","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"1871_CR40","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3748\/wjg.v27.i11.990","volume":"27","author":"R Kumar","year":"2021","unstructured":"Kumar R, Priyadarshi RN, Anand U. Chronic renal dysfunction in cirrhosis: A new frontier in hepatology. World J Gastroenterol. 2021;27(11):990\u20131005.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"1871_CR41","first-page":"9","volume":"6","author":"E Yeung","year":"2004","unstructured":"Yeung E, Yong E, Wong F. Renal dysfunction in cirrhosis: diagnosis, treatment and prevention. MedGenMed. 2004;6(4):9.","journal-title":"MedGenMed"},{"issue":"8","key":"1871_CR42","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00063-017-0263-3","volume":"113","author":"P H\u00fcbener","year":"2018","unstructured":"H\u00fcbener P, Braun G, Fuhrmann V. [Acute-on-chronic liver failure: a diagnostic and therapeutic challenge for intensive care]. Med Klin Intensivmed Notfmed. 2018;113(8):649\u201357.","journal-title":"Med Klin Intensivmed Notfmed"},{"issue":"1","key":"1871_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4103\/aip.aip_46_19","volume":"4","author":"A Banerjee","year":"2020","unstructured":"Banerjee A, et al. Depression and anxiety in patients with chronic liver disease and their relationship with quality of life. Annals Indian Psychiatry. 2020;4(1):28\u201332.","journal-title":"Annals Indian Psychiatry"},{"key":"1871_CR44","doi-asserted-by":"publisher","first-page":"1469372","DOI":"10.3389\/fpsyt.2024.1469372","volume":"15","author":"J Long","year":"2024","unstructured":"Long J, et al. Mental health disorder in chronic liver disease: a questionnaire survey. Front Psychiatry. 2024;15:1469372.","journal-title":"Front Psychiatry"},{"key":"1871_CR45","doi-asserted-by":"publisher","first-page":"566212","DOI":"10.3389\/fpsyg.2020.566212","volume":"11","author":"AL Pedrosa","year":"2020","unstructured":"Pedrosa AL, et al. Emotional, behavioral, and psychological impact of the COVID-19 pandemic. Front Psychol. 2020;11:566212.","journal-title":"Front Psychol"},{"key":"1871_CR46","doi-asserted-by":"publisher","first-page":"1405594","DOI":"10.3389\/fpsyt.2024.1405594","volume":"15","author":"W Zhang","year":"2024","unstructured":"Zhang W, et al. Illness uncertainty, resilience, and perceived social support among patients with Moyamoya disease: a cross-sectional study. Front Psychiatry. 2024;15:1405594.","journal-title":"Front Psychiatry"},{"issue":"1","key":"1871_CR47","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.1038\/s41598-025-86600-z","volume":"15","author":"X Zhang","year":"2025","unstructured":"Zhang X, et al. Intolerance of uncertainty and mental health in patients with IBD: the mediating role of maladaptive coping. Sci Rep. 2025;15(1):6464.","journal-title":"Sci Rep"},{"issue":"4","key":"1871_CR48","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s00103-022-03515-0","volume":"65","author":"F Thaiss","year":"2022","unstructured":"Thaiss F. [Long-term physical and psychological consequences of chronic kidney disease]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022;65(4):488\u201397.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"14","key":"1871_CR49","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1056\/NEJMsa012528","volume":"346","author":"TR Fried","year":"2002","unstructured":"Fried TR, et al. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002;346(14):1061\u20136.","journal-title":"N Engl J Med"},{"issue":"1","key":"1871_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.33393\/dti.2021.2342","volume":"15","author":"S Losi","year":"2021","unstructured":"Losi S, et al. The role of patient preferences in adherence to treatment in chronic disease: a narrative review. Drug Target Insights. 2021;15(1):13\u201320.","journal-title":"Drug Target Insights"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-025-01871-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-025-01871-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-025-01871-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:19:52Z","timestamp":1758719992000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-025-01871-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1871"],"URL":"https:\/\/doi.org\/10.1186\/s12904-025-01871-7","relation":{},"ISSN":["1472-684X"],"issn-type":[{"type":"electronic","value":"1472-684X"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed by the Ethics Committee of the University of T\u00fcbingen, which confirmed that no formal approval was required due to the anonymized and non-interventional design (Reference Number: 599\/2024BO2). All participants provided informed consent prior to study inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}